The FDA has issued a warning letter to Novo Nordisk for violating postmarketing adverse drug experience regulations that include failure to report adverse events among patients taking GLP-1s. Chronic ...
Abstract: This paper presents a high accuracy current sensor based on CMOS $0.18\mu \mathrm{m}$ technology. A specially designed current sensing amplifier (CSA) is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results